Module 7
Data Integrity in Electronic Systems, Data Governance and Auditing
Course Overview
This course establishes the essential understanding needed to manage, use, review and audit electronic data in a regulated pharmaceutical environment. It shows how electronic records, computerised systems, audit trails, user access controls, system configuration, data transfers, backups and data governance all affect patient safety, product quality, licence accountability and regulatory trust.
As pharmaceutical organisations increasingly rely on electronic systems, data integrity is no longer a specialist concern owned by QA, QC or IT. Electronic data are created and used across the whole business, including production systems, laboratory systems, electronic batch records, QMS platforms, training systems, warehouse systems, engineering systems, environmental monitoring systems, ERP platforms, regulatory document systems and supplier portals. Every person who enters, changes, reviews, approves, extracts, transfers or relies on electronic information has a role in protecting its integrity.
Drawing on 21 CFR Part 11, EU GMP Annex 11 and current regulatory expectations for data governance, this course explains how electronic data must be controlled throughout its lifecycle. It also develops the practical skills needed to recognise electronic data integrity risks, escalate concerns, support audit readiness and contribute to a culture where electronic records can be trusted.
Learning Outcomes
By the end of this course, learners will be able to:
- Explain why electronic data integrity is essential to patient safety, product quality, batch release, licence compliance and regulatory confidence.
- Describe how electronic records, electronic signatures, metadata, audit trails, system configuration and user access controls support trustworthy GMP decisions.
- Recognise how different departments create, use or rely on electronic GMP data, including QA, QC, production, engineering, warehouse, supply chain, IT, regulatory affairs, training, procurement and senior leadership.
- Identify common electronic data integrity risks, including shared logins, excessive privileges, disabled audit trails, uncontrolled spreadsheets, incomplete audit trail review, poor backup practices, unofficial data extracts and undocumented system workarounds.
- Understand the core expectations of 21 CFR Part 11 and EU GMP Annex 11 at a practical user, system owner and quality oversight level.
- Explain the purpose of audit trail review and distinguish between meaningful review and mechanical box-ticking.
- Recognise when electronic data concerns require escalation through the local PQS, including unexplained data changes, missing data, access concerns, system failures, data transfer errors, audit trail anomalies or pressure to bypass controls.
- Support electronic data integrity audits by understanding what auditors look for, what evidence is required and how findings should be linked to root cause and CAPA.
- Understand how local SOPs, system ownership, access management, backup processes, periodic review and data governance responsibilities apply within the organisation’s own PQS.
3.5Hrs of instructor led learning
Usable documents and templates
Real work examples and exercises
Course Content
Electronic systems now sit at the centre of pharmaceutical operations. Batch records, laboratory results, deviation investigations, CAPA records, training evidence, supplier approvals, temperature data, maintenance logs, environmental monitoring results, regulatory documents and batch release decisions often depend on electronic information. If that information is incomplete, inaccurate, inaccessible, manipulated or poorly controlled, the organisation may not be able to prove that the product is safe, compliant or suitable for release.
The move from paper to electronic systems has not removed data integrity risk. In many cases, it has made the risk harder to see. A missing signature on paper is obvious. A poorly configured user role, an unreviewed audit trail, an uncontrolled spreadsheet calculation, a hidden data transfer failure or an administrator account used inappropriately may sit unnoticed until an inspection, investigation or product issue exposes it.
This course is essential because electronic data integrity is a shared responsibility. IT may manage infrastructure, QA may provide oversight, and validation specialists may qualify systems, but the data are generated and used by people across the organisation. A laboratory analyst, warehouse operator, engineer, production supervisor, regulatory associate, training administrator, procurement user or senior manager can all make decisions that affect whether electronic records remain trustworthy.
Regulators do not simply ask whether a system exists. They ask whether it is controlled, validated where required, secure, reviewed, backed up, understood by its users and governed by competent people. A beautifully validated system used badly is still a compliance problem, rather like buying a very expensive safe and then leaving the key under the mat.
Paper, Hybrid and Fully Electronic Records
The course begins by comparing paper, hybrid and fully electronic records, explaining how the data integrity risk profile changes when information is created, modified, stored, reviewed, transferred or archived electronically. Learners will understand the difference between a visible record and the wider data set that supports it, including raw data, metadata, audit trails, system configuration, electronic signatures and linked records.
The Regulatory Framework: 21 Cfr Part 11 and EU GMP Annex 11
The regulatory framework is then introduced in practical terms. The course explains the purpose of 21 CFR Part 11 and EU GMP Annex 11, focusing on the expectations that matter most in daily pharmaceutical operations: electronic record reliability, electronic signatures, system validation, access control, audit trails, data retention, system security, backup, recovery, change control and periodic review.
Audit Trails and Meaningful Review
A major section focuses on audit trails. Learners will understand what an audit trail is, why it matters, what types of activity it should capture, and how audit trail review supports product quality and data integrity. The course explains how to review audit trails meaningfully, how to identify unusual or high-risk events, and how to avoid the common failure of treating audit trail review as an administrative ritual rather than a quality control. Clicking “reviewed” without understanding what was reviewed is not oversight; it is theatre with a password.
User Access and Privilege Management
The course then covers user access and privilege management. This includes unique user IDs, password expectations, role-based access, administrator rights, segregation of duties, removal of leavers, management of temporary users, contractor access and periodic access review. Learners will understand why shared accounts, excessive privileges and informal access changes create serious data integrity exposure.
The Electronic Data Lifecycle
The course also examines the full electronic data lifecycle. This includes data creation, processing, review, approval, transfer, reporting, backup, archive, retrieval and destruction. Particular attention is given to data transfers between systems, spreadsheets, interfaces, exported reports, cloud-hosted platforms, supplier-managed systems and hybrid processes where paper and electronic evidence coexist.
Electronic Data Integrity Across Departments
The course applies electronic data integrity expectations across departments, using examples such as:
- QC laboratory systems, LIMS, chromatography systems and instrument
- Manufacturing execution systems and electronic batch
- QMS platforms for deviations, CAPA, change control and
- Warehouse management systems and temperature-monitoring
- Engineering maintenance systems and calibration
- Training and learning management
- Regulatory document management
- ERP systems used for materials, suppliers, inventory and batch
- Environmental monitoring and building management
- Supplier portals and outsourced service.
Backup, Archive and Disaster Recovery
A dedicated section addresses backup, disaster recovery and business continuity. Learners will understand why data must remain available, readable and retrievable throughout its retention period, and why backup processes must be tested rather than assumed. The course also explains the difference between backup, archive and disaster recovery, because confusing these terms is a surprisingly efficient way to look uncomfortable in front of an inspector.
Auditing Electronic Data Integrity
The second half of the course focuses on auditing electronic data integrity. Learners will be introduced to practical audit planning, risk-based system selection, walkthrough techniques, interview approaches, evidence sampling, audit trail challenge, access control review, data flow mapping and identification of red flags. The course explains how to write findings that address the real weakness, not just the visible symptom, and how CAPA should correct the underlying governance or control failure.
Linking to the Local PQS
The course concludes by linking electronic data integrity to the local Pharmaceutical Quality System. Learners will understand how local SOPs, system ownership, business process ownership, QA oversight, IT support, supplier management, validation, change control, incident management and periodic review must work together to keep electronic data reliable.
- Employees, contractors and third parties who create, enter, modify, review, approve, extract, transfer, store or rely on electronic GMP data.
- System owners and business process owners responsible for regulated electronic
- QA professionals responsible for electronic data integrity, audit trail review, QMS oversight or inspection readiness.
- QC analysts, laboratory managers and technical specialists using laboratory computerised.
- Production, packaging and warehouse personnel using electronic batch records, MES, ERP, WMS or temperature-monitoring systems.
- Engineering, maintenance and validation personnel using calibration, maintenance, environmental monitoring or building management systems.
- IT, digital, automation and CSV/CSA professionals supporting GMP.
- Regulatory affairs, pharmacovigilance and medical information interface teams using controlled electronic records or regulated document systems.
- Procurement and supplier quality teams managing outsourced electronic platforms or supplier.
- Internal auditors and compliance specialists assessing data integrity.
- Senior leaders and department managers accountable for resources, governance, escalation and quality culture.
You will gain a practical understanding of how electronic data integrity works in real pharmaceutical environments, not just in policy documents. You will be able to recognise when an electronic record can be trusted, when a system control is weak, when audit trail review is meaningful, and when a concern needs to be escalated.
The course will help you speak confidently with QA, IT, validation, system owners, auditors and inspectors. It will also help you understand your own responsibilities when using electronic systems, approving electronic records, reviewing data, managing users, responding to system issues or supporting inspections.
For those moving into system ownership, quality oversight, laboratory leadership, validation, auditing or digital transformation roles, this module provides a valuable bridge between day-to-day system use and more advanced computerised system validation or software assurance training.
Organisations benefit from a workforce that understands electronic data integrity as a business-wide responsibility. This reduces the risk of unreliable records, inappropriate access, poor audit trail review, weak data governance, uncontrolled spreadsheets, system workarounds, incomplete backups and inspection findings linked to electronic systems.
The course supports stronger system ownership, better collaboration between QA and IT, more effective audit programmes, clearer escalation of electronic data concerns and improved confidence in the data used for batch release, quality decisions, regulatory submissions and management review.
It also helps organisations avoid a common and expensive mistake: assuming that system validation alone guarantees data integrity. Validation can show that a system is capable of working correctly. It does not prove that people are using it properly, reviewing it intelligently or governing it effectively. That is where competence, culture and oversight earn their keep.
- Comprehensive expert video
- Real-world case studies from pharmaceutical manufacturing, laboratory, warehouse, engineering, IT, quality systems and regulatory environments.
- Practical examples of electronic, paper and hybrid data integrity
- Cross-functional scenarios showing how different departments affect electronic data reliability and regulatory trust.
- Exercises on audit trail review, access control concerns, electronic record risk, data lifecycle mapping and escalation through the local PQS.
- Practical auditing scenarios covering walkthroughs, interviews, evidence sampling, red flag identification, finding writing and CAPA linkage.
- Multi-choice assessment.
- Certificate of completion upon passing the assessment.
Course Details
Instructor(s):
Paul Palmer & Aneta Jell
Level:
Practitioner
Duration:
3.5 Hours
Type:
Instructor led
Launch Yourself Into The Future.
Join Academy Pharmaceutical Excellence to gain industry-leading knowledge and skills through our comprehensive courses designed for aspiring professionals.